Please provide your email address to receive an email when new articles are posted on . When comparing continuous vs. intermittent infusions, the absolute difference in 90-day mortality was ...

Lower risk seen for 90-day mortality and intensive care unit mortality. HealthDay News — Among adults in the intensive care unit with sepsis or septic shock, the use of prolonged β-lactam antibiotic ...

Maintenance doses of the biologic agent infliximab (Remicade) can be safely administered at a patient's home with a very low rate of adverse events (AEs) and serious AEs, according to research ...

Extended infusion of beta-lactam therapy was associated with reduced mortality in patients with severe gram-negative bloodstream infections, according to a retrospective cohort study. At 90 days, 22% ...

About The Study: Among adults in the intensive care unit who had sepsis or septic shock, the use of prolonged β-lactam antibiotic infusions was associated with a reduced risk of 90-day mortality ...

About The Study: The observed difference in 90-day mortality between continuous versus intermittent infusions of β-lactam antibiotics did not meet statistical significance in the primary analysis.

DENVER & MAHWAH, N.J.--(BUSINESS WIRE)-- ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. (KRMD) today jointly announced an agreement leveraging KORU Medical’s FreedomEDGE® infusion system as ...